by John McMillan | Jan 10, 2025 | COVID-19, Immune Response
Dr. Philip McMillan, John McMillan The scene in Chinese hospitals today brings back haunting memories of early 2020. Nurses rush between beds, faces masked but eyes revealing the strain of double-digit shifts. Parents clutch feverish children, wheelchair bound...
by John McMillan | Dec 13, 2024 | Cancer, Diet
Justin Stebbing, Anglia Ruskin University King Charles’s decision to cut red meat from his diet following his cancer treatment has sparked a frenzy of interest in the potential effect of what we eat on cancer outcomes, and how well people do after they’re diagnosed....
by John McMillan | Aug 23, 2024 | COVID-19, Health
Sheena Cruickshank, University of Manchester This summer has seen a large COVID wave – one which is showing potential to be bigger than the 2023 winter wave was. The current wave has largely been driven by the so-called FLiRT variants, which have acquired greater...
by John McMillan | Aug 16, 2024 | Health, Medical Research
Tatiane Vilaca, University of Sheffield and Richard Eastell, University of Sheffield A new anti-osteoporosis drug has just been approved for use in the UK. The drug, called abaloparatide, is licensed for post-menopausal women with osteoporosis and a very high risk of...
by John McMillan | Aug 16, 2024 | Health, Virology
C Raina MacIntyre, UNSW Sydney The World Health Organization (WHO) has declared mpox a public health emergency of international concern, after rising cases in the Democratic Republic of the Congo and the potential for further spread. This now triggers a coordinated...
Recent Comments